A Clinical Study With MT-102 in Subjects With Cancer Cachexia

PHASE2CompletedINTERVENTIONAL
Enrollment

87

Participants

Timeline

Start Date

April 30, 2011

Primary Completion Date

May 31, 2013

Study Completion Date

May 31, 2013

Conditions
Cancer Cachexia
Interventions
DRUG

MT-102

BETA BLOCKER

Trial Locations (18)

10

Kumaran Hospital Private Ltd, Kilpauk

10990

Penang General Hopsital, Pulau Pinang

16150

Hospital Universiti Sains Malaysia, Kubang Kerian

25200

International Islamic University Malaysia, Kuantan

50603

Universiti Malaya Medical, Jalan Baharu

56000

Hospital Universiti Kebangsaan Malaysia, Cheras

70300

Tuanku Ja'afar Hospital, Seremban

93586

Hospital Umum Sarawak, Kuching

380009

Vedanta Institute of Medical Science, Ahmedabad

388325

Shree Krishna Hopsital, Anand

391760

Kailash Cancer Hospital & Research Centre, Goraj

400012

TATA Memorial Hopsital, Mumbai

411013

Noble Hopsital, Pune

422004

Curie Manavta Cancer Centre, Nashik

422005

Shatabdi Super Speciality Hospital, Nashik

600100

Dr Kamakshi Memorial Hospital, Pallikaranai

d-13352

Charite Hospital Virchow-Klinikum Campus, Berlin

05460

Hospital Sultahan Bahiyah, Alor Star

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Veeda Oncology

OTHER

lead

Akamis Bio

INDUSTRY

NCT01238107 - A Clinical Study With MT-102 in Subjects With Cancer Cachexia | Biotech Hunter | Biotech Hunter